FindTrial
Sign In

Additive to Subarachnoid block

Double Blinded Randomized Controlled Trial To Compare Post-Operative Analgesic Effect Of Dexmedetomidine And Morphine As Adjuvant To Intrathecal Bupivacaine In Infra-umbilical Surgeries

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/09/045775
Enrollment
64
Registered
2022-09-22
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: dexmedetomidine: receiving 15 mg of 0.5% hyperbaric bupivacaine and 5 �µg dexmedetomidine Control Intervention1: morphine: 15 mg of 0.5% hyperbaric bupivacaine and 125 �µg morphine.

Sponsors

SRM Medical College and Research Center Kattangulathur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.ASA I-II 2.Patients undergoing lower abdominal surgeries. 3.Elective Surgeries 4.Willing patients.

Exclusion criteria

Exclusion criteria: 1.Emergency surgeries. 2.Patients who are not willing. 3.ASA IV graded patients. 4.Patients not fit for spinal anaesthesia.

Design outcomes

Primary

MeasureTime frame
duration of analgesiaTimepoint: 24hrs postoperative period—

Secondary

MeasureTime frame
complicationsTimepoint: 24hrs postoperative period—

Countries

India

Contacts

Public ContactDr K Mullai Nayaki

SRM Medical College and Research Center

mullai1696@gmail.com9962049481

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026